Regardless of how risks are framed, patients seem hesitant to use topical steroids for atopic dermatitis.

Autor: Maghen, P., Unrue, E.L., Oussedik, E., Cline, A., Cardwell, L.A., Feldman, S.R.
Předmět:
Zdroj: British Journal of Dermatology; Oct2019, Vol. 181 Issue 4, p842-844, 3p
Abstrakt: Dear Editor, Topical corticosteroids are highly effective in treating atopic dermatitis (AD); however, patients often fear their potential adverse events.[1] This fear may be exacerbated by risk aversion. To assess the effect of "framing", we assessed whether patients with a history of AD were more willing to take a topical corticosteroid treatment when the treatment benefits were rephrased as the risk of not taking treatment. [Extracted from the article]
Databáze: Complementary Index